|
Study period (days)
|
3.2 (2-5)
|
2.8 (1-5)
|
0.18
|
|
Incidence severe hypoglycemia (<2.2 mmol/L)1
|
None
|
None
| |
|
Detected by CGM
| | | |
|
Number of subjects
|
3 (4%)
|
4 (5%)
|
1.0
|
|
Episodes < 2.2 mmol/L
|
3
|
4
| |
|
% of time for the reference glucose level (SD)3
| | | |
|
In target range (5.0-9.0 mmol/L)
|
69 (26)
|
66 (26)
|
0.47
|
|
Below target range (2.2-5.0 mmol/L)
|
5 (7)
|
3 (5)
|
0.21
|
|
Mild/moderate hypoglycemia (2.2-3.9)
|
1 (3)
|
0 (1)
|
0.03
|
|
Above target range (>9.0 mmol/L)
|
28 (26)
|
34 (27)
|
0.06
|
|
Mild/moderate hyperglycemia (9.0-11.1)
|
17 (16)
|
26 (23)
|
0.01
|
|
Hyperglycemia (>11.1)
|
11(19)
|
7(14)
|
0.19
|
|
% of time for the sensor glucose levels (SD)3
| | | |
|
In target range (5.0-9.0 mmol/L)
|
75 (18)
|
71 (20)
|
0.18
|
|
Below target range (2.2-5.0 mmol/L)
|
11 (13)
|
9 (12)
|
0.44
|
|
Mild/moderate hypoglycemia (2.2-3.9)
|
2 (7)
|
1 (2)
|
0.14
|
|
Above target range (>9.0 mmol/L)
|
15 (16)
|
20 (21)
|
0.06
|
|
Mild/moderate hyperglycemia (9.0-11.1)
|
12 (11)
|
16 (16)
|
0.03
|
|
Hyperglycemia (>11.1)
|
3 (7)
|
4 (9)
|
0.35
|
|
Mean reference blood glucose (mmol/L)
|
8.2 (1.6)
|
8.3 (1.3)
|
0.53
|
|
Mean sensor glucose (mmol/L)
|
7.1 (1.1)
|
7.5 (1.3)
|
0.07
|
|
MAG change (mmol/L/h)2
|
0.33 (0.2-0.5)
|
0.32(0.2-0.4)
|
0.31
|
|
LOS ICU (hours)
|
137 (71-250)
|
95 (51-157)
|
0.04
|
|
LOS hospital (days)
|
15 (8-270)
|
14 (8-31)
|
0.91
|
|
Mortality ICU
|
15 (19%)
|
12 (15%)
|
0.67
|
|
Mortality hospital
|
22 (28%)
|
17 (22%)
|
0.46
|
